Friday, January 16, 2015 2:46:48 PM
IMO, now medtronic (and any other company interested in Robotic surgery, ISRG, Stryker, Olympus, etc, etc, etc) needs to identify how to capitalize on robust surgical robotics market growth that is currently taking place. If you saw ISRG's info yesterday, robotic procedures have increase 10% and expected to continue to grow at that pace - so more procedures are being done robotically and only ISRG is reaping the benefit.
Then if Titan can hit the Q1 milestone, get design freeze at that point it is seeing who will pay the most for Titan.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM